Latest filing published 08 Sept 2023 for Surface Oncology, Inc..
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Jeff Goater (board member) discloses dealings in Surface Oncology, Inc. to SEC (Form 4). Between 3 February 2020 and 8 September 2023, the trades on record add up to 15 filings.
The open-market side counts 1 purchase for €15k alongside 6 sales for €2.3M. The net balance comes to €2.3M on the selling side. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. The rest of the record consists of 1 share grant and 6 option exercises.
The record was last updated on 8 September 2023 with a transaction in Surface Oncology, Inc. The most recent open-market purchase was published on 7 February 2020, 2,450 days ago. Typically, a trade is published a median of 2 days after it takes place. The legal deadline for a Form 4 is two business days after the transaction. Keep in mind that insiders sell for many reasons unrelated to the outlook, from tax bills to estate planning. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
3 of 3 declarations